Posted by admin on May 19th, 2022

StockNews.com upgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) from a hold rating to a buy rating in a research report report published on Wednesday.

A number of other brokerages have also recently weighed in on XRAY. Bank of America cut DENTSPLY SIRONA from a buy rating to a neutral rating and decreased their price objective for the company from $66.00 to $49.00 in a report on Tuesday, April 19th. William Blair lowered shares of DENTSPLY SIRONA from an outperform rating to a market perform rating in a report on Tuesday, April 19th. Credit Suisse Group cut their price objective on shares of DENTSPLY SIRONA from $68.00 to $67.00 and set an outperform rating for the company in a research note on Tuesday, March 1st. Robert W. Baird cut shares of DENTSPLY SIRONA from an outperform rating to a neutral rating and decreased their target price for the stock from $67.00 to $48.00 in a research report on Tuesday, April 19th. Finally, HC Wainwright cut their price target on shares of DENTSPLY SIRONA from $58.00 to $48.00 and set a hold rating for the company in a research report on Friday, April 22nd. Six investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of Hold and a consensus target price of $52.89.

XRAY stock opened at $37.62 on Wednesday. The firm has a 50 day simple moving average of $44.94 and a two-hundred day simple moving average of $50.82. The stock has a market cap of $8.11 billion, a PE ratio of 22.26 and a beta of 0.94. DENTSPLY SIRONA has a one year low of $35.00 and a one year high of $68.82. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.45 and a quick ratio of 1.03.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last announced its earnings results on Tuesday, May 10th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.56 by ($0.04). DENTSPLY SIRONA had a return on equity of 11.63% and a net margin of 8.81%. The company had revenue of $9.67 billion during the quarter, compared to analysts’ expectations of $982.05 million. During the same quarter last year, the firm posted $0.72 earnings per share. The firm’s revenue was up 841.1% on a year-over-year basis. On average, research analysts expect that DENTSPLY SIRONA will post 2.41 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 8th. Stockholders of record on Friday, March 25th were paid a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a dividend yield of 1.33%. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.11. The ex-dividend date was Thursday, March 24th. DENTSPLY SIRONA’s dividend payout ratio is 29.59%.

In related news, Director Eric Brandt sold 6,900 shares of the firm’s stock in a transaction dated Tuesday, May 3rd. The stock was sold at an average price of $39.71, for a total value of $273,999.00. Following the sale, the director now directly owns 35,155 shares of the company’s stock, valued at $1,396,005.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.76% of the company’s stock.

Large investors have recently added to or reduced their stakes in the stock. Worldquant Millennium Advisors LLC purchased a new stake in shares of DENTSPLY SIRONA in the 1st quarter worth about $12,912,000. KB Financial Partners LLC lifted its holdings in DENTSPLY SIRONA by 19.5% in the first quarter. KB Financial Partners LLC now owns 4,443 shares of the medical instruments supplier’s stock worth $219,000 after buying an additional 726 shares during the period. SkyView Investment Advisors LLC boosted its position in DENTSPLY SIRONA by 17.0% during the 1st quarter. SkyView Investment Advisors LLC now owns 4,878 shares of the medical instruments supplier’s stock valued at $240,000 after acquiring an additional 710 shares in the last quarter. Point72 Hong Kong Ltd purchased a new position in shares of DENTSPLY SIRONA during the 1st quarter worth approximately $970,000. Finally, Quantbot Technologies LP bought a new position in shares of DENTSPLY SIRONA in the 1st quarter worth approximately $2,331,000. Institutional investors and hedge funds own 94.79% of the company’s stock.

About DENTSPLY SIRONA (Get Rating)

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Albireo Pharma, Inc. (NASDAQ:ALBO) Forecasted to Post Q2 2022 Earnings of ($1.95) Per Share

IMARA (NASDAQ:IMRA) Stock Rating Lowered by Zacks Investment Research